Development of a Novel Anti-Cd19 Chimeric Antigen Receptor for a Spanish Approved Clinical Trial: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
Molecular Therapy - Methods and Clinical Development - United States
doi 10.1016/j.omtm.2018.11.010
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV